An Alteration in the Cecal Microbiota Composition by Feeding of 1-Kestose Results in a Marked Increase in the Cecal Butyrate Content in Rats

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Nov 19

PMID 27861621

Citations 17

Authors

Takumi Tochio

Yasuyuki Kitaura

Saki Nakamura

Chie Sugawa

Motoki Takahashi

Akihito Endo

Yoshiharu Shimomura

Affiliations

Soon will be listed here.

Abstract

Functional food ingredients, including prebiotics, have been ardently developed for improving the intestinal environment. Fructooligosaccarides (FOS), including fructans, are the well researched and commercialized prebiotics. However, to our knowledge, few studies have been conducted on the physiological effects of each component of FOS as prebiotics. 1-Kestose, a component of FOS, is composed of one glucose and two fructose molecules, and is considered as a key prebiotic component in short-chain FOS. In the present study, we examined the effects of dietary 1-kestose using 0.5-5% 1-kestose diets on cecal microbiota composition and cecal contents of short-chain fatty acids and lactate in rats. The findings indicate that dietary 1-kestose induced cecal hypertrophy and alterations in the cecal microbiota composition, including a marked increase in the cell number of Bifidobacterium spp. These alterations were associated with significant increases in acetate and lactate, and a marked increase in butyrate in cecal contents. Furthermore, dietary 1-kestose induced a significant decrease in serum insulin concentration in rats fed 2.5-5% 1-kestose diet. These findings suggest a potential of 1-kestose to be a prebiotic for improving the metabolism of the host.

Citing Articles

Alterations in Ileal Microbiota and Fecal Metabolite Profiles of Chickens with Immunity to .

Wang Z, Shang P, Song X, Wu M, Zhang T, Zhao Q Animals (Basel). 2024; 14(23).

PMID: 39682480 PMC: 11639942. DOI: 10.3390/ani14233515.

Administration of 1-kestose to beluga reduces intestinal Turicibacter and collagenase gene levels, and blood creatinine levels.

Fujii T, Kamio T, Akune Y, Takahashi H, Kondo N, Funasaka K J Vet Med Sci. 2024; 87(2):152-159.

PMID: 39631890 PMC: 11830438. DOI: 10.1292/jvms.24-0131.

Agarooligosaccharides as a novel concept in prebiotics: selective inhibition of and while preserving Bifidobacteria, Lactobacillales , and inhibiting Lachnospiraceae .

Fujii T, Karasawa K, Takahashi H, Shirai I, Funasaka K, Ohno E Microbiology (Reading). 2024; 170(11).

PMID: 39570663 PMC: 11581127. DOI: 10.1099/mic.0.001510.

Co-administration of the prebiotic 1-kestose and the paraprobiotic Lactiplantibacillus plantarum FM8 in magellanic penguins promotes the activity of intestinal Lactobacillaceae and reduces the plc gene levels encoding Clostridium perfringens toxin.

Fujii T, Kezuka C, Kawaguchi Y, Yamakawa S, Kondo N, Funasaka K J Vet Med Sci. 2024; 86(2):193-201.

PMID: 38171739 PMC: 10898991. DOI: 10.1292/jvms.23-0238.

Dietary supplementation with 1-kestose induces altered locomotor activity and increased striatal dopamine levels with a change in gut microbiota in male mice.

Altaisaikhan A, Yoshihara K, Hata T, Miyata N, Asano Y, Suematsu T Physiol Rep. 2023; 11(23):e15882.

PMID: 38054526 PMC: 10698829. DOI: 10.14814/phy2.15882.

References

Furusawa Y, Obata Y, Fukuda S, Endo T, Nakato G, Takahashi D . Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013; 504(7480):446-50. DOI: 10.1038/nature12721. View

Canfora E, Jocken J, Blaak E . Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol. 2015; 11(10):577-91. DOI: 10.1038/nrendo.2015.128. View

Molis C, Flourie B, Ouarne F, Gailing M, Lartigue S, Guibert A . Digestion, excretion, and energy value of fructooligosaccharides in healthy humans. Am J Clin Nutr. 1996; 64(3):324-8. DOI: 10.1093/ajcn/64.3.324. View

Delzenne N, Neyrinck A, Cani P . Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact. 2011; 10 Suppl 1:S10. PMC: 3231917. DOI: 10.1186/1475-2859-10-S1-S10. View

Zhang Y, Zhou L, Bao Y, Wu Y, Yu C, Huang Y . Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells. Chem Biol Interact. 2010; 185(3):174-81. DOI: 10.1016/j.cbi.2010.03.035. View

Bouhnik Y, Vahedi K, Achour L, Attar A, Salfati J, Pochart P . Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. J Nutr. 1999; 129(1):113-6. DOI: 10.1093/jn/129.1.113. View

Penders J, Stobberingh E, van den Brandt P, Thijs C . The role of the intestinal microbiota in the development of atopic disorders. Allergy. 2007; 62(11):1223-36. DOI: 10.1111/j.1398-9995.2007.01462.x. View

Campbell J, Fahey Jr G, Wolf B . Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J Nutr. 1997; 127(1):130-6. DOI: 10.1093/jn/127.1.130. View

Mortensen P, Clausen M . Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl. 1996; 216:132-48. DOI: 10.3109/00365529609094568. View

10.

Isolauri E . Development of healthy gut microbiota early in life. J Paediatr Child Health. 2012; 48 Suppl 3:1-6. DOI: 10.1111/j.1440-1754.2012.02489.x. View

11.

Jinno S, Nakamura Y, Nagata M, Takahashi T . 1-Kestose consumption during pregnancy and lactation increases the levels of IgA in the milk of lactating mice. Biosci Biotechnol Biochem. 2014; 78(5):861-6. DOI: 10.1080/09168451.2014.905179. View

12.

Endo A, Nakamura S, Konishi K, Nakagawa J, Tochio T . Variations in prebiotic oligosaccharide fermentation by intestinal lactic acid bacteria. Int J Food Sci Nutr. 2016; 67(2):125-32. DOI: 10.3109/09637486.2016.1147019. View

13.

Shibata R, Kimura M, Takahashi H, Mikami K, Aiba Y, Takeda H . Clinical effects of kestose, a prebiotic oligosaccharide, on the treatment of atopic dermatitis in infants. Clin Exp Allergy. 2009; 39(9):1397-403. DOI: 10.1111/j.1365-2222.2009.03295.x. View

14.

de Goffau M, Fuentes S, van den Bogert B, Honkanen H, de Vos W, Welling G . Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia. 2014; 57(8):1569-77. DOI: 10.1007/s00125-014-3274-0. View

15.

Paineau D, Respondek F, Menet V, Sauvage R, Bornet F, Wagner A . Effects of short-chain fructooligosaccharides on faecal bifidobacteria and specific immune response in formula-fed term infants: a randomized, double-blind, placebo-controlled trial. J Nutr Sci Vitaminol (Tokyo). 2014; 60(3):167-75. DOI: 10.3177/jnsv.60.167. View

16.

Mashige F, Tanaka N, Maki A, Kamei S, Yamanaka M . Direct spectrophotometry of total bile acids in serum. Clin Chem. 1981; 27(8):1352-6. View

17.

Berni Canani R, Di Costanzo M, Leone L, Pedata M, Meli R, Calignano A . Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol. 2011; 17(12):1519-28. PMC: 3070119. DOI: 10.3748/wjg.v17.i12.1519. View

18.

Scott K, Martin J, Duncan S, Flint H . Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiol Ecol. 2013; 87(1):30-40. DOI: 10.1111/1574-6941.12186. View

19.

Merino-Aguilar H, Arrieta-Baez D, Jimenez-Estrada M, Magos-Guerrero G, Hernandez-Bautista R, Del Carmen Susunaga-Notario A . Effect of fructooligosaccharides fraction from Psacalium decompositum on inflammation and dyslipidemia in rats with fructose-induced obesity. Nutrients. 2014; 6(2):591-604. PMC: 3942719. DOI: 10.3390/nu6020591. View

20.

Pineiro M, Asp N, Reid G, Macfarlane S, Morelli L, Brunser O . FAO Technical meeting on prebiotics. J Clin Gastroenterol. 2008; 42 Suppl 3 Pt 2:S156-9. DOI: 10.1097/MCG.0b013e31817f184e. View